BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34449869)

  • 1. Circulating C-reactive protein increases lung cancer risk: Results from a prospective cohort of UK Biobank.
    Ji M; Du L; Ma Z; Xie J; Huang Y; Wei X; Jiang X; Xu J; Yin R; Wang Y; Dai J; Jin G; Xu L; Zhu C; Hu Z; Ma H; Zhu M; Shen H
    Int J Cancer; 2022 Jan; 150(1):47-55. PubMed ID: 34449869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis.
    Zhu Y; Wei Y; Zhang R; Dong X; Shen S; Zhao Y; Bai J; Albanes D; Caporaso NE; Landi MT; Zhu B; Chanock SJ; Gu F; Lam S; Tsao MS; Shepherd FA; Tardon A; Fernández-Somoano A; Fernandez-Tardon G; Chen C; Barnett MJ; Doherty J; Bojesen SE; Johansson M; Brennan P; McKay JD; Carreras-Torres R; Muley T; Risch A; Wichmann HE; Bickeboeller H; Rosenberger A; Rennert G; Saliba W; Arnold SM; Field JK; Davies MPA; Marcus MW; Wu X; Ye Y; Le Marchand L; Wilkens LR; Melander O; Manjer J; Brunnström H; Hung RJ; Liu G; Brhane Y; Kachuri L; Andrew AS; Duell EJ; Kiemeney LA; van der Heijden EH; Haugen A; Zienolddiny S; Skaug V; Grankvist K; Johansson M; Woll PJ; Cox A; Taylor F; Teare DM; Lazarus P; Schabath MB; Aldrich MC; Houlston RS; McLaughlin J; Stevens VL; Shen H; Hu Z; Dai J; Amos CI; Han Y; Zhu D; Goodman GE; Chen F; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):935-942. PubMed ID: 30700444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3).
    Muller DC; Hodge AM; Fanidi A; Albanes D; Mai XM; Shu XO; Weinstein SJ; Larose TL; Zhang X; Han J; Stampfer MJ; Smith-Warner SA; Ma J; Gaziano JM; Sesso HD; Stevens VL; McCullough ML; Layne TM; Prentice R; Pettinger M; Thomson CA; Zheng W; Gao YT; Rothman N; Xiang YB; Cai H; Wang R; Yuan JM; Koh WP; Butler LM; Cai Q; Blot WJ; Wu J; Ueland PM; Midttun Ø; Langhammer A; Hveem K; Johansson M; Hultdin J; Grankvist K; Arslan AA; Le Marchand L; Severi G; Johansson M; Brennan P
    Ann Oncol; 2018 Jun; 29(6):1468-1475. PubMed ID: 29617726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium.
    Muller DC; Larose TL; Hodge A; Guida F; Langhammer A; Grankvist K; Meyer K; Cai Q; Arslan AA; Zeleniuch-Jacquotte A; Albanes D; Giles GG; Sesso HD; Lee IM; Gaziano JM; Yuan JM; Hoffman Bolton J; Buring JE; Visvanathan K; Le Marchand L; Purdue MP; Caporaso NE; Midttun Ø; Ueland PM; Prentice RL; Weinstein SJ; Stevens VL; Zheng W; Blot WJ; Shu XO; Zhang X; Xiang YB; Koh WP; Hveem K; Thomson CA; Pettinger M; Engström G; Brunnström H; Milne RL; Stampfer MJ; Han J; Johansson M; Brennan P; Severi G; Johansson M
    BMJ; 2019 Jan; 364():k4981. PubMed ID: 30606716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein and risk of lung cancer.
    Chaturvedi AK; Caporaso NE; Katki HA; Wong HL; Chatterjee N; Pine SR; Chanock SJ; Goedert JJ; Engels EA
    J Clin Oncol; 2010 Jun; 28(16):2719-26. PubMed ID: 20421535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically Determined Chronic Low-Grade Inflammation and Hundreds of Health Outcomes in the UK Biobank and the FinnGen Population: A Phenome-Wide Mendelian Randomization Study.
    Si S; Li J; Tewara MA; Xue F
    Front Immunol; 2021; 12():720876. PubMed ID: 34386016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).
    Huang JY; Larose TL; Luu HN; Wang R; Fanidi A; Alcala K; Stevens VL; Weinstein SJ; Albanes D; Caporaso NE; Purdue MP; Ziegler RG; Freedman ND; Lan Q; Prentice RL; Pettinger M; Thomson CA; Cai Q; Wu J; Blot WJ; Shu XO; Zheng W; Arslan AA; Zeleniuch-Jacquotte A; Le Marchand L; Wilkens LR; Haiman CA; Zhang X; Stampfer MJ; Han J; Giles GG; Hodge AM; Severi G; Johansson M; Grankvist K; Langhammer A; Hveem K; Xiang YB; Li HL; Gao YT; Visvanathan K; Ueland PM; Midttun Ø; Ulvi A; Buring JE; Lee IM; Sesso HD; Gaziano JM; Manjer J; Relton C; Koh WP; Brennan P; Johansson M; Yuan JM
    Int J Cancer; 2020 May; 146(9):2394-2405. PubMed ID: 31276202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis.
    Zhu M; Ma Z; Zhang X; Hang D; Yin R; Feng J; Xu L; Shen H
    BMC Med; 2022 Sep; 20(1):301. PubMed ID: 36117174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Sectional Study to Establish the Utility of Serum Tumor Markers in the Diagnosis of Lung Cancer.
    Mehta A; Parkash A; Bhatia M
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2569-2576. PubMed ID: 34452572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-diagnostic C-reactive protein and albumin predict survival in Chinese patients with non-small cell lung cancer: a prospective cohort study.
    Yang JR; Xu JY; Chen GC; Yu N; Yang J; Zeng DX; Gu MJ; Li DP; Zhang YS; Qin LQ
    Sci Rep; 2019 May; 9(1):8143. PubMed ID: 31148582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic correlation and causal associations between circulating C-reactive protein levels and lung cancer risk.
    Shi J; Wen W; Long J; Xue H; Yang Y; Tao R; Pan W; Shu XO; Cai Q
    Cancer Causes Control; 2024 Jun; 35(6):897-906. PubMed ID: 38332239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional Association Between Cardiovascular Disease and Lung Cancer in a Prospective Cohort Study.
    Zhang S; Liu L; Shi S; He H; Shen Q; Wang H; Qin S; Chang J; Zhong R
    J Thorac Oncol; 2024 Jan; 19(1):80-93. PubMed ID: 37703998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers.
    Akamine T; Takada K; Toyokawa G; Kinoshita F; Matsubara T; Kozuma Y; Haratake N; Takamori S; Hirai F; Tagawa T; Okamoto T; Yoneshima Y; Okamoto I; Shimokawa M; Oda Y; Nakanishi Y; Maehara Y
    Surg Oncol; 2018 Mar; 27(1):88-94. PubMed ID: 29549910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between idiopathic pulmonary fibrosis and risk of different pathological types of lung cancer: a Mendelian randomization study.
    Zheng H; Nie D; Huang X
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7751-7757. PubMed ID: 37009919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of telomere length with risk of lung cancer: A large prospective cohort study from the UK Biobank.
    Han D; Zhu Y; Choudhry AA; Cheng J; Liang H; Lin F; Chang Q; Liu H; Pan P; Zhang Y
    Lung Cancer; 2023 Oct; 184():107358. PubMed ID: 37696218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically Predicted Circulating C-Reactive Protein Concentration and Colorectal Cancer Survival: A Mendelian Randomization Consortium Study.
    Hua X; Dai JY; Lindström S; Harrison TA; Lin Y; Alberts SR; Alwers E; Berndt SI; Brenner H; Buchanan DD; Campbell PT; Casey G; Chang-Claude J; Gallinger S; Giles GG; Goldberg RM; Gunter MJ; Hoffmeister M; Jenkins MA; Joshi AD; Ma W; Milne RL; Murphy N; Pai RK; Sakoda LC; Schoen RE; Shi Q; Slattery ML; Song M; White E; Marchand LL; Chan AT; Peters U; Newcomb PA
    Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1349-1358. PubMed ID: 33972368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein partially mediates the inverse association between coffee consumption and risk of type 2 diabetes: The UK Biobank and the Rotterdam study cohorts.
    Ochoa-Rosales C; van der Schaft N; Braun KVE; Ho FK; Petermann-Rocha F; Ahmadizar F; Kavousi M; Pell JP; Ikram MA; Celis-Morales CA; Voortman T
    Clin Nutr; 2023 May; 42(5):661-669. PubMed ID: 36940600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
    Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Mendelian randomization to evaluate the causal relationship between serum C-reactive protein levels and age-related macular degeneration.
    Han X; Ong JS; An J; Hewitt AW; Gharahkhani P; MacGregor S
    Eur J Epidemiol; 2020 Feb; 35(2):139-146. PubMed ID: 31900758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum urate levels and neurodegenerative outcomes: a prospective cohort study and mendelian randomization analysis of the UK Biobank.
    Zhang T; An Y; Shen Z; Yang H; Jiang J; Chen L; Lu Y; Xia Y
    Alzheimers Res Ther; 2024 May; 16(1):106. PubMed ID: 38730474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.